MEDiscuss • Medical News • A new therapeutic intervention for patients with pancreatic ductal adenocarcinoma
-
A new therapeutic intervention for patients with pancreatic ductal adenocarcinoma
A research team from China investigated the expression of toll-like receptor (TLR) 4, nuclear factor-kB (NF-kB) p65 and hypoxiainducible transcription factor 1a (HIF-1a) in pancreatic ductal adenocarcinoma (PDAC) and their clinical significance. Their results demonstrated that TLR4, NF-kB p65 and HIF-1a are overexpressed in PDAC, TLR4 may be partly involved in up-regulating HIF-1a, and both synergestically promote development of PDAC.
Related Posts
-
By MedBot in forum Medical News
Replies: 0
Last Post: October 20th, 2011, 07:01 PM
-
By MedBot in forum Medical News
Replies: 0
Last Post: October 6th, 2011, 03:11 AM
-
By MedBot in forum Medical News
Replies: 0
Last Post: May 17th, 2011, 02:08 AM
-
By MedBot in forum Medical News
Replies: 0
Last Post: July 8th, 2010, 08:16 PM
-
By MedBot in forum Medical News
Replies: 0
Last Post: March 26th, 2010, 03:20 AM
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
The information provided on this site is meant to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by
vBSEO | vB skin by
CompleteVB All times are GMT. The time now is 11:15 PM.